Patients with inflammatory bowel disease: their response to information leaflets about medical therapy in particular azathioprine.
Thirty-eight patients with inflammatory bowel disease who had been treated with azathioprine were asked to complete an anonymous questionnaire about information they had received on the drug. Twenty responded of which 16 recalled having had information on azathioprine. Recall of the content on an information leaflet was poor with up to 25% of patients failing to recall warnings about side effects. Documentation of this advice on the clinical notes was also poor with this happening in only one case. This failure to both recall and record information must increase the chances of successful litigation.
Ward
B
B
Leicester General Hospital, Department of Gastroenterology, UK.
Shah
S
S
Eaden
J A
JA
Mayberry
J F
JF
D001379:Azathioprine / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D010353:Patient Education as Topic; D011795:Surveys and Questionnaires
D007166:Immunosuppressive Agents; D001379:Azathioprine